Te-Yu Hung Selected Research

Te-Yu Hung Research Topics

3	Seizures (Absence Seizure) 04/2021 - 01/2018
2	Pneumococcal Infections 01/2022 - 11/2017
2	Infections 01/2022 - 01/2022
2	Glioma (Gliomas) 01/2021 - 01/2016
2	Neoplasms (Cancer) 11/2017 - 12/2011
2	Vivax Malaria 01/2005 - 03/2004
2	Malaria 03/2004 - 01/2004
1	Nervous System Diseases (Neurological Disorders) 02/2024
1	Necrotizing Pneumonia 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Epilepsy (Aura) 04/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2019
1	Central Nervous System Diseases (CNS Diseases) 08/2019
1	Autism Spectrum Disorder 07/2014
1	Intellectual Disability (Idiocy) 07/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2014
1	Cerebral Palsy (Spastic Diplegia) 07/2014
1	Neurodevelopmental Disorders 07/2014
1	Encephalitis (Encephalitis, Rasmussen) 12/2011
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 12/2011
1	Metabolic Diseases (Metabolic Disease) 01/2008
1	Birth Weight (Birth Weights) 01/2008
1	Septic Shock (Toxic Shock Syndrome) 03/2005
1	Cardiotoxicity 01/2005

3	Pilocarpine (Ocusert)FDA LinkGeneric 04/2021 - 01/2018
3	piperaquineIBA 01/2005 - 01/2004
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021 - 01/2021
2	LithiumIBA 04/2021 - 08/2019
2	artenimol (dihydroartemisinin)IBA 03/2004 - 01/2004
1	Syntex adjuvant formulationIBA 02/2024
1	Vancomycin FDA LinkGeneric 01/2022
1	Panton-Valentine leukocidinIBA 01/2022
1	VaccinesIBA 01/2022
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022
1	brivaracetamIBA 04/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 01/2021
1	Vigabatrin FDA Link 01/2021
1	Pioglitazone (Actos)FDA Link 08/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2019
1	Conjugate VaccinesIBA 11/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Alkylating AgentsIBA 01/2016
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	AntibodiesIBA 12/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011
1	N-Methylaspartate (NMDA)IBA 12/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2008
1	LatexIBA 03/2005
1	Chloroquine (Aralen)FDA LinkGeneric 01/2005

2	Therapeutics 11/2017 - 01/2004
1	Artificial Respiration (Mechanical Ventilation) 07/2014
1	Immunotherapy 12/2011